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Abstract 
Purpose: To develop an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-
MS/MS) method for the simultaneous determination of 7 major components of Ginkgo leaf (kaempferol, 
quercetin, isorhamnetin, ginkgolides A, ginkgolides B, ginkgolides C and bilobalide) in dog plasma. 
Methods: Beagle dog plasma samples were spiked with internal standard (domperidone), acidified with 
HCl and extracted twice by liquid-liquid extraction using ethyl acetate. Chromatographic separation was 
achieved on an Acquity UPLC BEH C18 column (100 x 2.1 mm, 1.7 µm) by gradient elution with a run 
time of 4.0 min. The specificity, linearity, precision, recovery, matrix effect and stability of the method 
were determined. 
Results: The method showed high selectivity of the flavonols and terpene lactones in plasma samples. 
The concentration of the 7 target compounds showed good linear relationship with the peak area ratios 
of each analyte to internal standard. Lower limit of quantification (LLOQ) was 1.232, 0.240, 0.200, 
1.330, 0.960, 0.696, 0.470 ng•mL-1 for kaempferol, quercetin, isorhamnetin, bilobalide, ginkgolides A, 
ginkgolides B and ginkgolides C, respectively. Recovery of all QC samples ranged from 77.68 to 105.07 
%. Matrix effect derived from QC samples was in the range of 85.09 – 113.14 %. The stability of the 
analytes, calculated as RSD at three concentrations, was < 15 %. 
Conclusion: The developed method is simple, rapid and sensitive and can be applied to the 
determination of kaempferol, quercetin, isorhamnetin, ginkgolides A, ginkgolides B, ginkgolides C and 
bilobalide in dog plasma. 
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The extract of Ginkgo biloba (Ginkgo, 
Ginkgoaceae) leaves has been considered as 
valuable medicine and dietary supplements for 
more than 40 years. Pharmacology experiments 
showed that it is helpful to the prevention and 
treatment of cardiovascular diseases [1,2] and 
cerebral insufficiency [3-7]. Such 
pharmacological activities are attributed to the 
flavonoid glycosides and terpene lactones. 
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According to the Food and Drug Administration 
of the United States, botanical drug products 
should be investigated with regard to blood levels 
of known representative markers, active 
constituents, and major chemical constituents. 
 
In this study, a simple, rapid and sensitive ultra-
performance liquid chromatography-tandem 
mass spectrometry (UPLC-MS/MS) method was 
developed for the simultaneous determination of 
the 7 major components Ginkgo Biloba leaves 
(kaempferol, quercetin, isorhamnetin, ginkgolides 
A, ginkgolides B, ginkgolides C and bilobalide) in 






The reference standards of kaempferol (KMF), 
quercetin (QCT), isorhamnetin (ISR), ginkgolides 
A (GA), ginkgolides B (GB), ginkgolides C (GC) 
and bilobalide (BB) and domperidone (DPD) (IS) 
were purchased from the National Institute for 
the Control of Pharmaceutical and Biological 
Products (Beijing, China). The purity of QCT and 
GC was 96.5 and 97.1 %, respectively. The 
purity of the remaining reference standards was 
more than 99 %. LC/MS grades of methanol and 
acetonitrile were obtained from Fisher Scientific 
(Fair Lawn, NJ, USA), HPLC grade of formic acid 
was supplied by ROE Scientific (Newcastle, 
USA), and ultrapure water was generated from 
the Synergy UV water purification system 
(Millipore Corp, USA). 
 
Instrumentation and chromatographic 
conditions 
 
The UPLC–MS/MS system used was composed 
of an Acquity UPLC system (Waters Corp., 
Milford, MA, USA) and a TQS triple quadrupole 
tandem mass spectrometer (Waters Corp., 
Milford, MA, USA) equipped with an electrospray 
ionization (ESI) source. Data were acquired and 
processed using MassLynx 4.1 software (Waters 
Corp., Milford, MA, USA).  
 
Chromatographic separation was performed on 
an ACQUITY UPLC BEH C18 column (100 mm × 
2.1 mm ID, 1.7 µm; Waters Corp., Milford, MA, 
USA). The column temperature was maintained 
at 40 °C and the auto-sampler was conditioned 
at 4 °C. The mobile phase was composed of 0.1 
% formic acid aqueous solution (A) and 
acetonitrile (B) at a flow rate of 0.4 mL/min in 
only 4.0 minutes. Gradient condition of the 
mobile phase was as follows: 5 % B at 0–1.0 
min; 5 → 40 % B at 1.0–1.5 min; 40 % → 43 % B 
at 1.5–3.0 min, then the system was equilibrated 
using the initial condition (acetonitrile–water, 
5:95, v/v) for 1.0 min. The injection volume was 3 
µL and the partial loop with a needle overfill 
mode was used for sample injection. 
 
Mass spectrometer was operated in the negative 
ion mode using a multiple reaction monitoring 
(MRM) approach. Cone voltage was set at 30 V, 
and source and desolvation temperatures were 
set at 150 and 400 °C, respectively. Nitrogen 
was used as the desolvation gas and cone gas 
with the flow rates of 800 and 150 L/h, 
respectively. Argon was used as the collision gas 
at a pressure of approximately 3.4×10-3 mbar. 
The specific parameters for each analyte are 
shown in Table 1. 
 
Preparation of standards and quality control 
 
Seven separate primary stock solutions for KMF, 
QCT, ISR, BB, GA, GB, and GC were prepared 
by dissolving the accurately weighed reference 
compounds in methanol at the concentrations of 
110, 125, 123, 104, 100, 145, 147 μg/mL, 
respectively. The stock solutions were then 
mixed together and serially diluted with methanol 
to produce a series of standard or quality control 
(QC) working solutions at the desired 
concentrations. 
 
DPD (IS) was also prepared as a stock solution 
of 192 μg/mL in methanol and diluted with 
methanol to yield a working solution of 576 
ng/mL. 
 















KMF MRM 284.954 150.930 76 20 Negative 
QCT MRM 301.072 150.929 54 18 Negative 
ISR MRM 315.018 300.031 68 20 Negative 
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All these solutions were stored at 4 °C and 
brought to room temperature before the solutions 
were used.  
 
The calibration samples were prepared by 
spiking 500 µL blank beagle dog plasma with 20 
µL standard working solutions and 20 µL IS 
working solutions to obtain final concentrations of 
1.232, 3.08, 6.16, 15.4, 30.8, 77.0, 154.0, 385.0, 
and 770.0 ng/mL for KMF; 0.24, 0.6, 1.2, 3.0, 
6.0, 15.0, 30.0, 75.0, and 150.0 ng/mL for QCT; 
0.197, 0.492, 0.984, 2.46, 4.92, 12.3 24.6, 61.5, 
and 123.0 ng/mL for ISR; 1.331, 3.328, 6.656, 
16.64, 33.28, 83.2, 166.4, 416.0, and 832.0 
ng/mL for BB; 0. 96, 2.4, 4.8, 12.0, 24.0, 60.0, 
120.0, 300.0, and 600.0 ng/mL for GA; 0.696, 
1.74, 3.48, 8.7, 17.4, 43.5, 87.0, 217.5, and 
435.0 ng/mL for GB; and 0.470, 1.176, 2.352, 
5.88, 11.76, 29.4, 58.8, 147.0, and 294.0 ng/mL 
for GC. Low-, medium-, and high-level QC 
samples were also prepared in the same way to 
obtain concentrations of 3.08, 30.8, and 616 
ng/mL, respectively, for KMF; 0.6, 6.0, and 120 
ng/mL, respectively, for QCT; 0.492, 4.92, and 
98.4 ng/mL, respectively, for ISR; 3.328, 33.28, 
and 665.6 ng/mL, respectively, for BB; 2.4, 24.0, 
and 480 ng/mL, respectively, for GA; 1.74, 17.4, 
and 348 ng/mL, respectively, for GB; and 1.176, 
11.76, and 235.2 ng/mL, respectively, for GC. 
 
Animals and sample handling 
 
Male adult beagle dogs (SPF animal, 11.1 ± 0.3 
kg, certificate number SCXK（Jing）2013-0007) 
were obtained from the Beijing Tongli 
experimental animal farms. Animals were housed 
in a temperature-controlled house. Water and 
standard laboratory food were available ad 
libitum. The experimental protocols were 
conducted in accordance with The Guiding 
Principles for the Care and Use of Laboratory 
Animal (published by Ministry of Science and 
Technology of the People’s Republic of China, 
Chapters 2, 3 and 5) and were approved by the 
Institutional Animal Care and Use Committee of 
the Beijing University of Chinese Medicine. 
 
Blood samples were collected before and after 
the drug administration. The steps of the sample 
treatments are described as follows: 500 µL 
plasma was placed in an Eppendorf tube; then 
20 µL of IS solution and 500 µL of 25 % 
hydrochloric acid were added to the tube and the 
mixture was vortex mixed for 1 min. Then the 
plasma sample was hydrolyzed for 30 min in a 
water bath at 80 °C, and the hydrolyzed and 
cooled sample was vortex mixed for 3 min after 
adding 2.0 mL acetidin. The mixture was 
centrifuged at 8000 rpm for 10 min to separate 
the water phase from the organic phase (I). The 
water phase was repeatedly spiked with 2 mL 
acetidin by vortex mixing for 3 min and 
centrifuged at 8000 rpm for 10 min to separate 
the water phase from the organic phase (II). The 
organic phase (I) and the organic phase (II) were 
put together and transferred to a clean centrifuge 
tube. The mixture was evaporated to dryness 
under a gentle stream of nitrogen. The residue 
was reconstituted with 200 μL methanol; then the 
solution was centrifuged at 12000 rpm for 15 
min, and finally, an aliquot of 3 μL of the solution 







Selectivity was evaluated by comparing the 
chromatograms of six individual blank dog 
plasma samples with those of corresponding 
standard plasma samples spiked with the 
analytes and IS, and plasma samples obtained 
after oral administration of drugs. 
 
Calibration curves and LLOQ 
 
To evaluate linearity, the calibration curves were 
confirmed by plotting the peak area ratios of 
each analyte to IS versus the concentration of 
calibration samples through the linear least 
squares regression calculation with the suitable 
weighting factor of 1/x. A correlation coefficient 
(r) should be greater than 0.99 for assessment of 
linearity. The concentrations of QC samples or 
the test samples were calculated using the 
regression equations gained from the calibration 
curves. The LLOQ for the analytes were the 
lowest concentration point of the calibration 
curve. Analytes response at the level of LLOQ 
should be at least five times that of the blank 
plasma. 
 
Recovery and matrix effect  
 
The extraction recoveries and matrix effects of 
analytes were determined by analyzing six 
replicates of QC samples at three concentration 
levels. The extraction recoveries were calculated 
by comparing the response obtained from QC 
samples spiked before extraction with those from 
QC samples spiked in post-extracted blank dog 
plasma at the same concentrations. The matrix 
effects were evaluated by comparing the 
response obtained from QC samples spiked 
post-extraction blank dog plasma with those from 
QC samples spiked in before extracted pure 
water at the same concentrations. The matrix 
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effects should be neglected if the ratio is in the 
range of 85 – 115 %.  
 
Intra- and inter-day precision 
 
Precision were evaluated by analysis of QC 
samples at low, medium and high concentrations 
with six replicates on the same day and three 
consecutive days. Precision was expressed as 
the intra- and inter-day RSD. The precisions 
were required to be less than 15 %, except for 
the low QC samples where the precision should 




Stability studies were conducted at three QC 
levels with three replicates in different conditions 
that occurred during sample analysis. The short-
term stability was evaluated with QC samples 
stored at room temperature for 6 h. The long-
term stability was assessed by QC samples kept 
at -80 °C for 1 month. The post-preparative 
stability was measured by determining QC 
samples maintained in the auto-sampler 
conditions at 4 °C for 12 h. The samples were 
considered to be stable if the deviation from the 
nominal concentration was within the acceptable 




Specificity and selectivity 
 
Fig 1 showed the representative chromatograms 
of blank plasma sample, Fig 2 showed the 
chromatograms of plasma sample spiked with 
KMF (2.79 min), QCT (2.53 min), ISR (2.86 min), 
BB (2.42 min), GA (2.61 min), GB (2.60 min), GC 
(2.34 min), and IS (2.35 min), Fig 3 showed the 
chromatograms of plasma sample at 120 min 
after oral administration of Ginkgo leaf extraction 
preparations. The chromatograms from the 
bottom up in proper order are: KMF, QCT, ISR, 
BB, GA, GB, IS and GC, respectively. 
 
Linearity and LLOQ 
 
Table 2 lists the regression equation, correlation 
coefficients, linearity ranges, and LLOQ of the 
analytes. All calibration curves exhibited good 
linearity with the correlation coefficients (r) higher 
than 0.9952. The LLOQ were 1.232, 0.240, 
0.200, 1.330 0.960, 0.696, and 0.470 ng/mL for 
KMF, QCT, ISR, BB, GA, GB, and GC, 
respectively. 
  
The calibration curves were confirmed by plotting 
the peak area ratios of each analyte to IS versus 
the concentration of calibration samples through 
the linear least squares regression calculation 
with the suitable weighting factor of 1/x. 
 
Recovery and matrix effect  
 
The extraction recoveries and matrix effects of all 
analytes at different levels of concentrations are 
shown in Table 3. The recoveries of three-level 
QC samples ranged from 77.68 % to 105.07 %. 
The matrix effects derived from QC samples 
were in the range of 85.09 % – 113.14 %. The 
results showed that the plasma matrix effect was 
negligible under the current conditions. 
 
Intra- and inter-day precision 
 
The intra- and inter-day precisions are shown in 
Table 4. The precisions of KMF, QCT, ISR, BB, 
GA, GB, and GC calculated as the RSD at three 
concentrations were lower than 10 % for intra- 
and inter-day assays for quality control. The 
results demonstrated that the precision of this 




The stability experiments aimed at testing 
samples under all possible conditions the 
samples might experience after collection and 
prior to analysis. The summaries are listed in 
Table 5. The stability of the analytes calculated 
as the RSD at three concentrations was lower 
than 15 % for quality control. The results 





The method to determine the flavonol aglycones 
QCT, KMF, and ISR in G. biloba products was 
completed by a single laboratory validation [8], 
and the method was evaluated in the 
collaborative laboratory in 2007 [9]. A rapid 
quantitative analysis of GA, GB, GC, and GJ, 
and BB in ginkgo dietary supplements was 
established [10]. Up to now it is known that an 
LC–MS/MS was developed for simultaneous 
measurement of eight ginkgo flavonoids (QCT, 
KMF, and ISR) and terpenoids (BB, GA, GB, GC, 
and GJ) in vitro [11]. In a more recent study, on 
the basis of LC–MS/MS working in the MRM 
mode, an analytical method was established to 
simultaneously determine 24 main bioactive 
components, including flavonol glycosides, 
terpene lactones, biflavones, proanthocyanidins, 
and ginkgolic acids in G. biloba leaves [12]. FDA 
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Fig 1: Chromatogram of blank plasma sample 
 
 
Lu et al 




Fig 2: Chromatograms of blank plasma sample spiked with the seven Ginkgo components and IS 
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Fig 3: Chromatograms of plasma sample from a beagle dog at 120 min after a single oral administration of 
ginkgo leaf extraction preparation 
 
Table 2: Regression data and LLOQ of the analytes 
 
Compound The Regression Equation r Linearity Ranges (ng·mL-1) LLOQ 
KMF Y=0.1644X ± 0.2500 0.9994 1.232~770 1.232 
QCT Y=4.1719X ± 0.2012 0.9987 0.240~150 0.240 
ISR Y=9.0977X ± 0.9591 0.9995 0.200~123 0.200 
BB Y=0.4310X + 1.0351 0.9993 1.330~832 1.330 
GA Y=0.0425X + 0.0937 0.9952 0.960~600 0.960 
GB Y=3.6240X + 6.7713 0.9956 0.696~435 0.696 
GC Y=2.2237X + 1.2385 0.9987 0.470~294 0.470 
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Table 3: Extraction recovery and matrix effect of the analytes in beagle dog plasma (n = 6) 
 
Compound C (ng·mL-1) 
Extraction recovery Matrix effect 
(%, mean ± SD) RSD% (%, mean ± SD) RSD% 
KMF 
3.08 103.16 ± 8.17 8.02 95.13 ± 4.78 5.01 
30.8 79.63 ± 3.91 4.92 99.97 ± 5.18 5.18 
616 84.78 ± 3.67 4.32 92.66 ± 3.18 3.59 
QCT 
0.6 92.04 ± 4.27 4.63 105.21 ± 11.43 10.79 
6 83.50 ± 9.55 11.38 96.10 ± 13.00 13.94 
120 83.29 ± 4.76 5.70 86.12 ± 3.23 3.95 
ISR 
0.492 87.92 ± 17.07 19.55 100.14 ± 5.76 5.73 
4.92 81.00 ± 9.57 11.93 98.42 ± 5.08 10.63 
98.4 81.19 ± 2.26 2.78 94.88 ± 8.53 3.49 
BB 
3.328 104.33 ± 5.68 5.44 98.42 ± 5.08 5.16 
33.28 84.95 ± 8.43 9.85 94.88 ± 8.53 8.99 
665.6 80.21 ± 0.94 1.17 97.43 ± 1.43 1.47 
GA 
2.4 100.64 ± 7.87 7.84 97.32 ± 5.95 6.10 
24 81.71 ± 8.32 9.50 99.80 ± 4.71 4.60 
480 87.09 ± 4.33 4.97 91.76 ± 3.39 3.69 
GB 
1.74 94.98 ± 8.94 9.43 113.14 ± 2.22 1.96 
17.4 80.20 ± 10.87 13.45 89.80 ± 9.04 10.05 
348 77.86 ± 6.66 8.50 85.09 ± 6.49 8.18 
GC 
1.176 105.07 ± 5.00 4.75 93.62 ± 3.84 4.10 
11.76 97.91 ± 6.26 6.38 98.61 ± 7.65 7.74 
235.2 95.46 ± 2.64 2.77 103.09 ± 1.41 1.35 
 
Table 4: Precision of seven components in beagle dog plasma 
 
Compound C (ng·mL-1) 
RSD% 
Intraday (n=6) Interday (n=18) 
KMF 
3.08 13.58 5.67 
30.8 5.81 5.46 
616 12.11 2.35 
QCT 
0.6 15.57 3.38 
6 13.98 7.37 
120 9.56 9.78 
ISR 
0.492 9.79 6.14 
4.92 14.22 5.82 
98.4 13.26 1.37 
BB 
3.328 9.36 2.71 
33.28 4.55 6.50 
665.6 7.01 2.75 
GA 
2.4 7.90 11.47 
24 6.35 5.18 
480 7.41 5.27 
GB 
1.74 11.28 17.60 
17.4 5.42 11.81 
348 6.62 0.95 
GC 
1.176 13.44 8.25 
11.76 6.40 6.90 
235.2 7.92 2.31 
 
 
suggested that botanical drug products should be 
investigated with regard to blood levels of known 
representative markers, active constituents, and 
major chemical constituents. The 
pharmacokinetic studies of G. biloba and its 
preparations were mostly implemented in rats, 
which most only for flavonols or lactones of 
single preparation [13-17]. In this paper, a 
UPLC–ESI–MS/MS method for simultaneous 
determination of three flavonoids (KMF, QCT, 
and ISR) and four lactones (GA, GB, GC, and 
BB) in beagle dog plasma was described for the 
first time. In addition, the current method also 
offers other advantages over existing methods, 
such as shorter analysis time (4.0 min). This 
method can be applied to a pharmacokinetic 
study of different G. biloba L. extract 
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Table 5: Stability of the analytes in beagle dog plasma (n = 3) 
 
Compound C (ng·mL-1) 
RSD /% (n=3) 
Room temperature 
stability in 6 h 
Stability in autosampler 
6 h 12 h 
KMF 
3.08 1.27 0.60 7.20 
30.8 4.28 2.49 2.28 
616 3.50 0.74 4.83 
QCT 
0.6 11.35 9.51 11.97 
6 1.23 1.20 1.27 
120 6.70 4.70 5.53 
ISR 
0.492 4.14 5.30 8.59 
4.92 1.97 1.27 1.83 
98.4 1.09 2.22 2.01 
BB 
3.328 4.24 6.43 5.33 
33.28 2.21 3.14 0.62 
665.6 1.95 0.77 0.72 
GA 
2.4 2.94 13.68 3.34 
24 3.87 4.24 3.60 
480 4.11 4.71 1.06 
GB 
1.74 3.31 7.20 6.77 
17.4 1.12 1.54 1.33 
348 1.43 2.15 2.13 
GC 
1.176 3.68 3.90 10.35 
11.76 2.22 1.63 1.13 




The developed methods meet the requirements 
for biological sample analysis. 
 
They can be applied to the pharmacokinetic 
studies of kaempferol, quercetin, isorhamnetin, 
ginkgolides A, ginkgolides B, ginkgolides C and 
bilobalide in dog plasma when Ginkgo leaf 
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